Swedish Orphan Biovitrum AB/ SE0000872095 /
11/07/2025 17:29:49 | Chg. -6.80 | Volume | Bid17:29:49 | Ask17:29:49 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
285.80SEK | -2.32% | 162,607 Turnover: 46.62 mill. |
286.60Bid Size: 280 | 287.20Ask Size: 187 | 98.16 bill.SEK | - | 25.14 |
Business description
Swedish Orphan Biovitrum AB is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.
Management board & Supervisory board
CEO |
---|
Guido Oelkers |
Management board |
Henrik Stenqvist, Lydia Abad-Franch, Duane H. Barnes, Lena Bjurner, Sofiane Fahmy, Torbjörn Hallberg, Mahmood Ladha, Norbert Oppitz, Daniel Rankin, Christine Wesström |
Supervisory board |
David Meek, Christophe Bourdon, Staffan Schüberg, Katy Mazibuko, Mats Lek, Anders Ullman, Filippa Stenberg, Zlatko Rihter, Annette Clancy, Helena Saxon |
Company data
Name: | Swedish Orphan Biovitrum AB |
Address: | Norra Stationsgatan 93A,Stockholm |
Phone: | +46-8-697-2000 |
Fax: | - |
E-mail: | - |
Internet: | www.sobi.com |
Industry Group: | Healthcare |
Industry: | Healthcare products |
Sector: | Biotechnology |
Subsector: | Biotechnology |
End of financial year: | 31/12 |
Free Float: | 42.16% |
IPO date: | - |
Investor relations
Name: | Gerard Tobin |
IR phone: | +41 79 286 28 83 |
IR Fax: | - |
IR e-mail: | gerard.tobin@sobi.com |
Main Shareholders
Investor Aktiebolag | 34.52% | |
Others | 18.92% | |
Morgan Stanley Smith Barney Llc, W9 | 9.84% | |
Fjärde AP-fonden | 5.83% | |
AMF Fonder & Pension | 4.93% | |
State Street Bank And Trust Co, W9 | 3.99% | |
Swedbank Robur Fonder AB | 3.76% | |
Jp Morgan Chase Bank Na | 3.15% | |
Northern Trust Company, London Branch | 2.71% | |
Others | 12.35% |
Swedish Orphan Biovitrum AB/ SE0000872095 /
11/07/2025 15:29:49 | Chg. -6.80 | Volume | Bid15:29:49 | Ask15:29:49 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
285.80SEK | -2.32% | 162,607 Turnover: 46.62 mill. |
286.60Bid Size: 280 | 287.20Ask Size: 187 | 98.16 bill.SEK | - | 25.14 |
Master data
WKN: | A0LA5K |
---|---|
Ticker: | SOBI |
Currency: | SEK |
Type: | Stock |
Issue type: | Common stock |
Trading segment: | - |
Next exchange holiday: | 31/10/2025 |
Indices: STOXX Europe 600, Bats Europe Healthcare Sector, Bats Europe All Companies ex UK, Bats Europe All Companies, Bats Sweden 30 |
Quote data
Open: | 292.40 |
---|---|
High: | 292.40 |
Low: | 285.80 |
Previous Close: | 292.60 |
Volume (shares): | 162,607 |
Turnover: | 46.62 mill. |
Trades: | 1,058 |
Market phase: | CL |
All quotes in SEK
Latest news
Performance
1 Week | -0.76% | ||
---|---|---|---|
1 Month | -2.52% | ||
3 Months | +12.43% | ||
YTD | -9.96% | ||
1 Year | +0.28% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
1W High / 1W Low: | 292.60 | 283.60 |
---|---|---|
1M High / 1M Low: | 293.20 | 272.60 |
6M High / 6M Low: | 342.00 | 246.60 |
High (YTD): | 29/01/2025 | 342.00 |
Low (YTD): | 09/04/2025 | 246.60 |
52W High: | 25/10/2024 | 346.40 |
52W Low: | 09/04/2025 | 246.60 |
Avg. price 1W: | 286.60 | |
Avg. volume 1W: | 220,588.20 | |
Avg. price 1M: | 283.91 | |
Avg. volume 1M: | 294,626.38 | |
Avg. price 6M: | 298.77 | |
Avg. volume 6M: | 344,902.30 | |
Avg. price 1Y: | 303.39 | |
Avg. volume 1Y: | 371,515.89 | |
Volatility 1M: | 26.41% | |
Volatility 6M: | 29.47% | |
Volatility 1Y: | 31.33% | |
Volatility 3Y: | - | |
Dividend per Share: | - | |
Earnings per Share: | 11.37 SEK | |
Return on Equity: | 9.64% | |
Dividend Yield: | - | |
P/E Ratio: | 25.14 | |
Market Capitalization: | 98.16 bill. SEK | |
Free Float Market Cap.: | - |
You are using the free license of baha.com exclusively for private, non-commercial use. For professional users we offer the baha WebStation, contact us to arrange a demo.
Create a free account, or log in
Once registered, you can:
- Continue using baha.com with no limitations
- Create wachlists, portfolios and alerts
- Use our revolutionary app to access all baha.com features on the go.